SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT
                   Pursuant to Section 13 or 15(d) of the
                      Securities Exchange Act of 1934

 Date of Report (Date of Earliest Event Reported): January 8, 2002
                                                   (January 8, 2002)


                     ENDO PHARMACEUTICALS HOLDINGS INC.

           (Exact name of registrant as specified in its charter)


DELAWARE                           39040                         13-4022871

(State or other        (Commission File Number)                (I.R.S. Employer
jurisdiction of                                             Identification No.)
incorporation)


100 Painters Drive
Chadds Ford, Pennsylvania                                   19317

(Address of principal executive offices)                    (Zip Code)


                               (610) 558-9800

            (Registrant's telephone number, including area code)


                                    N/A

       (Former name or former address, if changed since last report)



Item 7.  Financial Statements and Exhibits.

(a)      Financial Statements of Business Acquired.

                  Not applicable.

(b)      Pro Forma Financial Information.

                  Not applicable.

(c)      Exhibits.

Exhibit Number             Description

       99.1                Slide Presentation of Endo Pharmaceuticals Holdings
                           Inc. dated January 8, 2002


Item 9.  Regulation FD Disclosure.


         On January 8, 2002, the Registrant intends to make a slide
presentation at the JPMorgan H&Q Healthcare Conference in San Francisco,
California, a copy of which presentation is filed herewith as Exhibit 99.1
and is incorporated herein by reference.


                                 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.


                           ENDO PHARMACEUTICALS HOLDINGS INC.
                                                      (Registrant)


                           By:   /s/ CAROLINE B. MANOGUE
                                ----------------------------------
                                Name:  Caroline B. Manogue
                                Title: Senior Vice President, General Counsel
                                       & Secretary





Dated:  January 8, 2002



                             INDEX TO EXHIBITS

Exhibit No.                         Description

       99.1                Slide Presentation of Endo Pharmaceuticals Holdings
                           Inc. dated January 8, 2002
[{"type": "8-K", "sequence": "1", "filename": "sendo.txt", "secsgml_size_bytes": 2831}]
{"company-data": {"conformed-name": "ENDO PHARMACEUTICALS HOLDINGS INC", "cik": "0001100962", "assigned-sic": "2834", "irs-number": "134022871", "state-of-incorporation": "DE", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "001-15989", "film-number": "2503689"}, "business-address": {"street1": "223 WILMINGTON-WEST CHESTER PIKE", "city": "CHADDS FORD", "state": "PA", "zip": "19317", "phone": "6105589800"}, "mail-address": {"street1": "223 WILMINGTON-WEST CHESTER PIKE", "city": "CHADDS FORD", "state": "PA", "zip": "19317"}}
SECURITIES AND EXCHANGE COMMISSION

                           Washington, D.C. 20549

                                  FORM 8-K

                               CURRENT REPORT
                   Pursuant to Section 13 or 15(d) of the
                      Securities Exchange Act of 1934

 Date of Report (Date of Earliest Event Reported): January 8, 2002
                                                   (January 8, 2002)

                     ENDO PHARMACEUTICALS HOLDINGS INC.

           (Exact name of registrant as specified in its charter)

DELAWARE                           39040                         13-4022871

(State or other        (Commission File Number)                (I.R.S. Employer
jurisdiction of                                             Identification No.)
incorporation)

100 Painters Drive
Chadds Ford, Pennsylvania                                   19317

(Address of principal executive offices)                    (Zip Code)

                               (610) 558-9800

            (Registrant's telephone number, including area code)

                                    N/A

       (Former name or former address, if changed since last report)

Item 7.  Financial Statements and Exhibits.

(a)      Financial Statements of Business Acquired.

                  Not applicable.

(b)      Pro Forma Financial Information.

                  Not applicable.

(c)      Exhibits.

Exhibit Number             Description

       99.1                Slide Presentation of Endo Pharmaceuticals Holdings
                           Inc. dated January 8, 2002

Item 9.  Regulation FD Disclosure.

         On January 8, 2002, the Registrant intends to make a slide
presentation at the JPMorgan H&Q Healthcare Conference in San Francisco,
California, a copy of which presentation is filed herewith as Exhibit 99.1
and is incorporated herein by reference.

                                 SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned, hereunto duly authorized.

                           ENDO PHARMACEUTICALS HOLDINGS INC.
                                                      (Registrant)

                           By:   /s/ CAROLINE B. MANOGUE
                                ----------------------------------
                                Name:  Caroline B. Manogue
                                Title: Senior Vice President, General Counsel
                                       & Secretary

Dated:  January 8, 2002

                             INDEX TO EXHIBITS

Exhibit No.                         Description

       99.1                Slide Presentation of Endo Pharmaceuticals Holdings
                           Inc. dated January 8, 2002